{"id":2681,"date":"2024-06-11T16:43:00","date_gmt":"2024-06-11T08:43:00","guid":{"rendered":"https:\/\/htbios.n.webweb.today\/news\/taipei-exchange-approves-hantech-bio-techs-tpex-listing-application-on-june-7\/"},"modified":"2026-08-27T10:11:44","modified_gmt":"2026-08-27T02:11:44","slug":"taipei-exchange-approves-hantech-bio-techs-tpex-listing-application-on-june-7","status":"publish","type":"news","link":"https:\/\/www.htbios.com\/en\/news\/taipei-exchange-approves-hantech-bio-techs-tpex-listing-application-on-june-7\/","title":{"rendered":"Taipei Exchange Approves HANTECH BIO-TECH’s TPEx Listing Application on June 7"},"content":{"rendered":"

HANTECH BIO-TECH Co., Ltd. (Stock Code: 1294) is primarily engaged in the R&D, manufacturing, and sale of health supplements and related ingredients. The company is chaired by Lee Yu-Lin, with CTBC Securities, First Securities, and Capital Securities serving as its recommending securities firms. At the time of application, the company’s paid-in capital was NTD 194.144 million.<\/p>\n

In 2023, HANTECH BIO-TECH reported consolidated operating revenue of NTD 625.141 million. Net profit after tax attributable to owners of the parent company was NTD 148.118 million, with earnings per share (EPS) of NTD 7.50.<\/p>\n

In the first quarter of 2024, consolidated operating revenue reached NTD 179.882 million. Net profit after tax attributable to owners of the parent company was NTD 35.625 million, with earnings per share (EPS) of NTD 1.78.<\/p>\n

Source:<\/p>\n

Taipei Exchange Press Release: https:\/\/www.tpex.org.tw\/web\/about\/news\/news\/news_detail.php?l=zh-tw&doc_id=11619<\/a><\/p>\n

\"\u6ac3\u8cb7\u4e2d\u5fc3\u65bc6\u67087\u65e5\u5be9\u8b70\u901a\u904e\u6f22\u7530\u751f\u6280\u516c\u53f8\u4e0a\u6ac3\u6848\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

HANTECH BIO-TECH Co., Ltd. (Stock Code: 1294) is primarily engaged in the R&D, manufacturing, and sale of health supplements and related ingredients. The company is chaired by Lee Yu-Lin, with CTBC Securities, First Securities, and Capital Securities serving as its recommending securities firms. At the time of application, the company’s paid-in capital was NTD 194.144 […]<\/p>\n","protected":false},"featured_media":2111,"parent":0,"menu_order":58,"template":"","news_category":[168],"class_list":["post-2681","news","type-news","status-publish","has-post-thumbnail","hentry","news_category-corporate-information"],"acf":{"news_is_featured":false,"news_featured_start":null,"news_featured_end":null,"news_content_image":null},"_links":{"self":[{"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/news\/2681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/media\/2111"}],"wp:attachment":[{"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/media?parent=2681"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/news_category?post=2681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}